MTORC1 signaling promotes osteoblast differentiation from preosteoblasts

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Chen, Jianquan ^a,b   Long, Fanxin ^c,d  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c WASHINGTON UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; OSTEOCALCIN; PROTEIN ALPL; PROTEIN BGLAP; PROTEIN COL1A; PROTEIN IBSP; PROTEIN RAPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; RPTOR PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOPHAGY; BONE DEVELOPMENT; BONE MATRIX; CALVARIA; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; MINERALIZATION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PHASE TRANSITION; POLYMERASE CHAIN REACTION; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL MODEL; BONE; BONE MINERALIZATION; CYTOLOGY; DIAGNOSTIC IMAGING; EXTRACELLULAR MATRIX; GENE DELETION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; RADIOGRAPHY; STEM CELL; TRANSGENIC MOUSE;

MUS; RAPTORES;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; GENE DELETION; MESENCHYMAL STROMAL CELLS; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; MULTIPROTEIN COMPLEXES; OSTEOBLASTS; RADIOGRAPHY; SIGNAL TRANSDUCTION; STEM CELLS; TOR SERINE-THREONINE KINASES;

EID: 84939236649     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130627     Document Type: Article

References (27)

1. Bellows CG, Heersche JN. The frequency of common progenitors for adipocytes and osteoblasts and of committed and restricted adipocyte and osteoblast progenitors in fetal rat calvaria cell populations. J Bone Miner Res. 2001; 16:1983-1993. PMID:11697794
2. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol. 2011; 13:27-38. doi:10.1038/nrm3254 PMID:22189423
3. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012; 149:274-293. doi:10.1016/j.cell.2012.03.017 PMID:22500797
4. Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell. 2010; 40:310-322. doi:10.1016/j.molcel.2010.09.026 PMID:20965424
5. Chen J, Long F. mTORC1 signaling controls mammalian skeletal growth through stimulation of protein synthesis. Development. 2014; 141:2848-2854. doi:10.1242/dev.108811 PMID:24948603
6. Chen J, Holguin N, Shi Y, Silva MJ, Long F. mTORC2 signaling promotes skeletal growth and bone formation in mice. J Bone Miner Res. 2015; 30:369-78. doi:10.1002/jbmr.2348 PMID:25196701
7. Chen J, Tu X, Esen E, Joeng KS, Lin C, Arbeit JM, et al. WNT7B promotes bone formation in part through mTORC1. PLoS Genet. 2014; 10 (1):e1004145. doi:10.1371/journal.pgen.1004145 PMID:24497849
8. Isomoto S, Hattori K, Ohgushi H, Nakajima H, Tanaka Y, Takakura Y. Rapamycin as an inhibitor of osteogenic differentiation in bone marrow-derived mesenchymal stem cells. J Orthop Sci. 2007; 12:83-88. PMID:17260122
9. Shoba LN, Lee JC. Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks osteogenic protein- 1 induction of alkaline phosphatase activity in fetal rat calvaria cells. J Cell Biochem. 2003; 88:1247-1255. PMID:12647306
10. Singha UK, Jiang Y, Yu S, Luo M, Lu Y, Zhang J, et al. Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells. J Cell Biochem. 2008; 103:434-446. PMID:17516572
11. Xian L, Wu X, Pang L, Lou M, Rosen CJ, Qiu T, et al. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med. 2012; 18:1095-1101. doi:10.1038/nm.2793 PMID:22729283
12. Chen C, Akiyama K, Wang D, Xu X, Li B, Moshaverinia A, et al. mTOR inhibition rescues osteopenia in mice with systemic sclerosis. J Exp Med. 2015; 212:73-91. doi:10.1084/jem.20140643 PMID:25534817
13. Lee KW, Yook JY, Son MY, Kim MJ, Koo DB, Han YM, et al. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Stem Cells Dev. 2010; 19:557-568. doi:10.1089/scd.2009.0147 PMID:19642865
14. Martin SK, Fitter S, Bong LF, Drew JJ, Gronthos S, Shepherd PR, et al. NVP-BEZ235, a dual pan class I PI3 kinase and mTOR inhibitor, promotes osteogenic differentiation in human mesenchymal stromal cells. J Bone Miner Res. 2010; 25:2126-2137. doi:10.1002/jbmr.114 PMID:20499346
15. Ogawa T, Tokuda M, Tomizawa K, Matsui H, Itano T, Konishi R, et al. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells. Biochem Biophys Res Commun. 1998; 249:226-230. PMID:9705862
16. Rodda SJ, McMahon AP. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 2006; 133:3231-3244. PMID:16854976
17. Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature. 2010; 468:1100-1104. doi:10.1038/nature09584 PMID:21179166
18. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25:1468-1486. doi:10.1002/jbmr.141 PMID:20533309
19. Liu F, Fang F, Yuan H, Yang D, Chen Y, Williams L, et al. Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation. J Bone Miner Res. 2013; 28:2414-2430. doi:10.1002/jbmr.1971 PMID:23633228
20. Onal M, Piemontese M, Xiong J, Wang Y, Han L, Ye S, et al. Suppression of autophagy in osteocytes mimics skeletal aging. J Biol Chem. 2013; 288:17432-17440. doi:10.1074/jbc.M112.444190 PMID:23645674
21. Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci. 2004; 117:2805-2812. PMID:15169837
22. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res. 1999; 14:893-903. PMID:10352097
23. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008; 2:313-319. doi:10.1016/j.stem.2008.03.002 PMID:18397751
24. Chen J, Shi Y, Regan J, Karuppaiah K, Ornitz DM, Long F. Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice. PLoS One. 2014; 9(1):e85161. doi:10.1371/journal.pone. 0085161 PMID:24454809
25. Esen E, Chen J, Karner CM, Okunade AL, Patterson BW, Long F. WNT-LRP5 Signaling Induces Warburg Effect through mTORC2 Activation during Osteoblast Differentiation.Cell Metab. 2013; 17:745-55. doi:10.1016/j.cmet.2013.03.017 PMID:23623748
26. Martin SK, Fitter S, Dutta AK, Matthews MP, Walkley CR, Hall MN, et al. The differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation. Stem Cells. 2015; 33(4): 1359-65. doi:10.1002/stem.1931 PMID:25537496
27. Sen B, Xie Z, Case N, Thompson WR, Uzer G, Styner M, et al. mTORC2 regulates mechanically induced cytoskeletal reorganization and lineage selection in marrow derived mesenchymal stem cells. J Bone Miner Res. 2014; 29(1):78-89. doi:10.1002/jbmr.2031 PMID:23821483